Gene · 9075
Papers2,543
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,543
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Claudin-2 enhances human antibody-mediated complement-dependent cytotoxicity of porcine endothelial cells by modulating antibody binding and complement activation. | Front Immunol | 2025 | 40040710 | PubTator, text mining | PubMed |
| Claudin-2 simplifies histological assessment of activity/remission of ulcerative colitis in real-life daily practice. | Eur J Gastroenterol Hepatol | 2025 | 39975995 | PubTator, text mining | PubMed |
| Human cathelicidin LL-37 rapidly disrupted colonic epithelial integrity. | Biochim Biophys Acta Biomembr | 2025 | 39837472 | PubTator, text mining | PubMed |
| Histological healing in IBD: Ready for prime time? | Dig Liver Dis | 2025 | 39828441 | PubTator, text mining | PubMed |
| Bioenergetic adaptations of small intestinal epithelial cells reduce cell differentiation enhancing intestinal permeability in obese mice. | Mol Metab | 2025 | 39814101 | PubTator, text mining | PubMed |
| In Vitro Infant Fecal Fermentation Metabolites of Osteopontin and 2'-Fucosyllactose Support Intestinal Barrier Function. | J Agric Food Chem | 2025 | 39705716 | PubTator, text mining | PubMed |
| Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse. | J Gastroenterol | 2025 | 39672976 | PubTator, text mining | PubMed |
| Regulation of keratinocyte barrier function and inflammatory response by the EGFR-STAT3 Pathway: Potential therapeutic implications of osimertinib and afatinib. | Cytokine | 2025 | 39612655 | PubTator, text mining | PubMed |
| Effects of Dietary Supplementation of Zinc Oxide Quantum Dots on Growth Performance and Gut Health in Broilers. | Biol Trace Elem Res | 2025 | 39292416 | PubTator, text mining | PubMed |
| Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases. | Dig Liver Dis | 2025 | 39155205 | PubTator, text mining | PubMed |
| Dietary ferulic acid improves growth performance of broilers via enhanced intestinal antioxidant capacity and barrier function. | Anim Biosci | 2025 | 38665075 | PubTator, text mining | PubMed |
| Inter-claudin antagonism of paracellular pore function: mechanism and beyond. | Tissue Barriers | 2025 | 38494648 | PubTator, text mining | PubMed |
| Effects of Magnesium Forms on the Magnesium Balance and Jejunal Transporters in Healthy Rats. | Prev Nutr Food Sci | 2024 | 39759820 | PubTator, text mining | PubMed |
| AhR-Induced Anti-Inflammatory Effects on a Caco-2/THP-1 Co-Culture Model of Intestinal Inflammation Are Mediated by PPARγ. | Int J Mol Sci | 2024 | 39684781 | PubTator, text mining | PubMed |
| [Cancer Malignancy by Abnormal Claudin Expression]. | Gan To Kagaku Ryoho | 2024 | 39648121 | PubTator, text mining | PubMed |
| Inflammation-Induced Claudin-2 Upregulation Limits Pancreatitis Progression by Enhancing Tight Junction-Controlled Pancreatic Ductal Transport. | bioRxiv | 2024 | 39605652 | PubTator, text mining | PubMed |
| Lactobacillus paracasei JY062 and its exopolysaccharide enhance the intestinal barrier through macrophage polarization and Th17/Treg cell balance. | Food Res Int | 2024 | 39593317 | PubTator, text mining | PubMed |
| Apical integrins as a switchable target to regulate the epithelial barrier. | J Cell Sci | 2024 | 39552289 | PubTator, text mining | PubMed |
| Insights into the unique roles of extracellular vesicles for gut health modulation: Mechanisms, challenges, and perspectives. | Curr Res Microb Sci | 2024 | 39525958 | PubTator, text mining | PubMed |
| Claudin2 is involved in the interaction between Megalocytivirus-induced virus-mock basement membrane (VMBM) and lymphatic endothelial cells. | Vet Res | 2024 | 39506812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9075/papers?page=6